Life Technologies Corp.  

(Public, NASDAQ:LIFE)   Watch this stock  
Find more results for LIFE
74.21
-0.06 (-0.08%)
After Hours: 74.21 0.00 (0.00%)
Jun 19, 4:32PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 74.06 - 74.27
52 week 40.50 - 74.48
Open 74.27
Vol / Avg. 1.76M/2.54M
Mkt cap 12.77B
P/E 31.35
Div/yield     -
EPS 2.37
Shares 172.08M
Beta 0.98
Inst. own 92%
Jul 29, 2013
Q2 2013 Life Technologies Corporation Earnings Release Add to calendar
May 30, 2013
Q1 2013 Life Technologies Corporation Earnings Release
Apr 15, 2013
Thermo Fisher Scientific Conference Call to Discuss its Definitive Agreement to Acquire Life Technologies Corporation - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 12.58% 11.33%
Operating margin 18.98% 17.51%
EBITD margin - 30.72%
Return on average assets 5.66% 4.83%
Return on average equity 10.41% 9.31%
Employees 10,000 -
Carbon Disclosure Rating - 80/100

Address

5791 Van Allen Way
CARLSBAD, CA 92008
United States - Map
+1-760-6037200 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha
Discussion Group - Google Finance

Description

Life Technologies Corporation (Life Technologies) is a global life sciences company. The Company's systems, consumables and services enable scientific researchers and commercial markets to accelerate scientific exploration, to discoveries and developments that improve the quality of life. The Company's products are also used in forensics, food and water safety, animal health testing and other industrial applications. In June 2012, the Company established Global Instrument Center of Excellence in Singapore. In July 2012, it acquired Pinpoint Genomics, Inc. In October 2012, the Company acquired Compendia Bioscience, a cancer bioinformatics company used by the pharmaceutical industry to identify gene targets for drug discovery and development. In November 2012, the Company acquired Advanced Microscopy Group (AMG). In April 2013, it announced the acquisition of KDR Biotech Co., Ltd. In June 2013, Life Technologies Corp announced the acquisition of Life Science Korea (LSK).

Officers and directors

Gregory T. Lucier Chairman of the Board, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Mark P. Stevenson President, Chief Operating Officer
Age: 50
Bio & Compensation  - Reuters
David F. Hoffmeister Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Ronnie A. Andrews President - Medical Sciences
Age: 53
Bio & Compensation  - Reuters
Peter Michael Leddy Ph.D. Senior Vice President - Global Human Resources and Internal Communications
Age: 49
Bio & Compensation  - Reuters
Kelli A. Richard Vice President - Finance, Chief Accounting Officer
Age: 44
Bio & Compensation  - Reuters
John A. Cottingham Chief Legal Officer, Secretary
Age: 58
Bio & Compensation  - Reuters
George F. Adam Jr. Independent Director
Age: 66
Bio & Compensation  - Reuters
Raymond V. Dittamore Independent Director
Age: 69
Bio & Compensation  - Reuters
Donald W. Grimm Independent Director
Age: 71
Bio & Compensation  - Reuters